Literature DB >> 21384276

Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in southern Italy.

Valentina Greco1, Elvira Valeria De Marco, Francesca Emanuela Rocca, Ferdinanda Annesi, Donatella Civitelli, Giovanni Provenzano, Patrizia Tarantino, Vittorio Scornaienchi, Franco Pucci, Maria Salsone, Fabiana Novellino, Maurizio Morelli, Sandra Paglionico, Antonio Gambardella, Aldo Quattrone, Grazia Annesi.   

Abstract

Iron overload may lead to neurodegenerative disorders such as Parkinson's disease (PD) and alterations of iron-related genes might be involved in the pathogenesis of this disease. The gene of haemochromatosis (HFE) encodes the HFE protein which interacts with the transferrin receptor (TFR), lowering its affinity for iron-bound transferrin (TF). We examined four known polymorphisms, C282Y and H63D in the HFE gene, G258S in the TF gene and S82G in the TFR gene, in 181 sporadic PD patients and 180 controls from Southern Italy to investigate their possible role in susceptibility to PD. No significant differences were found in genotype and allele frequencies between PD and controls for all the polymorphisms studied, suggesting that these variants do not contribute significantly to the risk of PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21384276     DOI: 10.1007/s10072-011-0504-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  15 in total

1.  The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.

Authors:  R L Oliveri; G Annesi; M Zappia; D Civitelli; E V De Marco; A A Pasqua; F Annesi; P Spadafora; A Gambardella; G Nicoletti; D Branca; M Caracciolo; U Aguglia; A Quattrone
Journal:  Mov Disord       Date:  2000-01       Impact factor: 10.338

Review 2.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

3.  Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Authors:  Nilgün Akbas; Helmine Hochstrasser; Joelle Deplazes; Jürgen Tomiuk; Peter Bauer; Uwe Walter; Stefanie Behnke; Olaf Riess; Daniela Berg
Journal:  Neurosci Lett       Date:  2006-08-28       Impact factor: 3.046

4.  Association study between iron-related genes polymorphisms and Parkinson's disease.

Authors:  Claire Borie; Francesca Gasparini; Patrice Verpillat; Anne-Marie Bonnet; Yves Agid; Gilles Hetet; Alexis Brice; Alexandra Dürr; Bernard Grandchamp
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

5.  Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.

Authors:  Elvira V De Marco; Grazia Annesi; Patrizia Tarantino; Francesca E Rocca; Giovanni Provenzano; Donatella Civitelli; Innocenza C Cirò Candiano; Ferdinanda Annesi; Sara Carrideo; Francesca Condino; Giuseppe Nicoletti; Demetrio Messina; Fabiana Novellino; Maurizio Morelli; Aldo Quattrone
Journal:  Mov Disord       Date:  2008-02-15       Impact factor: 10.338

6.  The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients.

Authors:  D D Buchanan; P A Silburn; J B Chalk; D G Le Couteur; G D Mellick
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

7.  HFE gene mutations in a population of Italian Parkinson's disease patients.

Authors:  Giorgio Biasiotto; Stefano Goldwurm; Dario Finazzi; Sara Tunesi; Anna Zecchinelli; Francesca Sironi; Gianni Pezzoli; Paolo Arosio
Journal:  Parkinsonism Relat Disord       Date:  2008-03-05       Impact factor: 4.891

8.  Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.

Authors:  Junwei Gao; Juxing Chen; Maxwell Kramer; Hidekazu Tsukamoto; An-Sheng Zhang; Caroline A Enns
Journal:  Cell Metab       Date:  2009-03       Impact factor: 27.287

9.  Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism.

Authors:  Marieke C J Dekker; Patricia C Giesbergen; Omer T Njajou; John C van Swieten; Albert Hofman; Monique M B Breteler; Cornelia M van Duijn
Journal:  Neurosci Lett       Date:  2003-09-11       Impact factor: 3.046

10.  Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort.

Authors:  Rita J Guerreiro; Jose M Bras; Isabel Santana; Cristina Januario; Beatriz Santiago; Ana S Morgadinho; Maria H Ribeiro; John Hardy; Andrew Singleton; Catarina Oliveira
Journal:  BMC Neurol       Date:  2006-07-06       Impact factor: 2.474

View more
  6 in total

1.  Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations.

Authors:  Margaret R DeWitt; Pan Chen; Michael Aschner
Journal:  Biochem Biophys Res Commun       Date:  2013-01-26       Impact factor: 3.575

2.  Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-03-29       Impact factor: 5.750

3.  Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review.

Authors:  Tarun Girotra; Abhimanyu Mahajan; Christos Sidiropoulos
Journal:  Case Rep Neurol Med       Date:  2017-03-23

4.  The Prevalence of Insomnia and the Link between Iron Metabolism Genes Polymorphisms, TF rs1049296 C>T, TF rs3811647 G>A, TFR rs7385804 A>C, HAMP rs10421768 A>G and Sleep Disorders in Polish Individuals with ASD.

Authors:  Karolina Skonieczna-Żydecka; Dominika Jamioł-Milc; Krzysztof Borecki; Ewa Stachowska; Paulina Zabielska; Magdalena Kamińska; Beata Karakiewicz
Journal:  Int J Environ Res Public Health       Date:  2020-01-08       Impact factor: 3.390

Review 5.  Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area.

Authors:  Yan Wang; Yong Wang; Minhua Zhou; Deqi Jiang; Xun Deng
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

6.  Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.

Authors:  Irene Pichler; Fabiola Del Greco M; Martin Gögele; Christina M Lill; Lars Bertram; Chuong B Do; Nicholas Eriksson; Tatiana Foroud; Richard H Myers; Michael Nalls; Margaux F Keller; Beben Benyamin; John B Whitfield; Peter P Pramstaller; Andrew A Hicks; John R Thompson; Cosetta Minelli
Journal:  PLoS Med       Date:  2013-06-04       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.